Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2021-10-04 Regulatory Filings
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Company Name Change and New ASX Code 'IRX' 2 pages 138.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 October 2021 regarding a company name change and new ASX code. It mentions shareholder approval at an Extraordinary General Meeting but does not contain financial data, detailed reports, or regulatory certifications. The document is short (2064 characters) and serves as a formal announcement of a corporate action (name and ticker change) rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements that do not fit other specific categories.
2021-10-04 English
EGM Presentation 12 pages 1.5MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation about the company's strategic direction, branding, team, and product development plans. It includes information about the company's vision, mission, values, strategic imperatives, and commercial activities. There are no financial statements, regulatory filings, voting results, or legal proceedings mentioned. The document is authored by the Board of Directors and appears to be aimed at investors and stakeholders to communicate the company's future plans and market positioning. This matches the characteristics of an Investor Presentation (IP). The document length is over 11,000 characters, indicating it is a full presentation rather than a brief announcement or summary.
2021-09-14 English
Results of Meeting 2 pages 151.1KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 15 September 2021 reporting the results of an Extraordinary General Meeting (EGM) of Lifespot Health Limited. It provides detailed voting results for resolutions including change of company name and election of directors. The document references ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, which pertain to disclosure of meeting results. The content is focused on official voting outcomes rather than the meeting materials or the meeting itself. The document length is short (2624 characters) and it is clearly a formal announcement of voting results from a shareholder meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-09-14 English
Half Yearly Report and Accounts 18 pages 1.3MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Lifespot Health Ltd Appendix 4D Half-year report' and covers the half-year ended 30 June 2021. It includes detailed financial statements such as the statement of profit or loss, statement of financial position, statement of changes in equity, and cash flows. It also contains a directors' report, auditor's independence declaration, and an independent auditor's review report. The presence of comprehensive financial data and analysis for a half-year period, along with the auditor's review, clearly indicates this is an interim financial report. The document is lengthy (15,000 characters) and contains substantive financial information, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-31 English
Change of Director's Interest Notice 4 pages 266.9KB
Director's Dealing Classification · 100% confidence The document is an ASX announcement titled 'Change of Director’s Interest Notice' and includes an Appendix 3Y form, which is a standard disclosure for changes in directors' shareholdings. It details the indirect acquisition of shares by a director through an entity, compliance with ASX Listing Rules, and the circumstances around the trade during a blackout period. There are no financial statements or management discussion of financial results, nor is this a report or presentation. The content is focused on insider trading disclosures by a director, which fits the definition of Director's Dealing filings.
2021-08-31 English
Change in substantial holding 2 pages 116.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of substantial holders in Lifespot Health Ltd, including dates and nature of transactions. This type of filing is a notification of changes in major shareholdings, not a financial report or other corporate announcement. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief announcement or a report publication notice, but a substantive notification of shareholding changes.
2021-08-18 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.